MedTrace Logo

Prodigy, a Level 2 Sleep Study Device, Validation Study

NCT05115305 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2022-07-20

No results posted yet for this study

Summary

The Prodigy system, developed by Cerebra Medical Ltd, allows for the generation of the same information in the home that is currently only obtained in in-laboratory studies.

The objective of the current study is to demonstrate that the signals obtained by this comprehensive, portable system are comparable to those obtained in in-laboratory studies.

Conditions

Sponsors & Collaborators

  • Cerebra Medical

    lead INDUSTRY

Principal Investigators

  • Amy Bender, PhD · Cerebra Medical

  • Raymond Gottschalk, MD · Hamilton Sleep Disorders Clinic

  • Mohammad Amin, MD · St Charles Sleep Disorders Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-14
Primary Completion
2022-04-09
Completion
2022-04-09

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05115305 on ClinicalTrials.gov